LOS GATOS, CA, Advanced NanoTherapies has closed on the final tranche of its seed-round financing.
Advanced NanoTherapies, a privately-held medical device company committed to exploring nanotechnology for enhanced drug uptake and sustained retention, today announced it has closed on the final tranche of its seed-round financing for a total of $5.3 million as a result of achieving a successful pre-clinical milestone. Funding came from a variety of angel investment sources in the US, Canada, Europe, Asia, and the Middle East, including venture funding from Cleveland Clinic and ForMed Ventures of Taiwan.
Co-founded by Marwan Berrada-Sounni, Advanced NanoTherapies is a highly specialized medical device company that is developing a nanoparticle technology-based platform for drug delivery. The company is currently focused on cardiovascular and endovascular applications to bring a safer therapeutic option to patients with PAD using Sirolimus-coated angioplasty balloons. To learn more about Advanced NanoTherapies, visit www.AdvNanoT.com.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about